The Clinical Studies Unit - Liver Diseases
Contact:
Mrs. Avishag Hassid
Mrs. Shani Dor-Hai
Mrs. Dana Silberberg
Phone: 03-5307179, 03-5307176
Fax: 03-5307338, 03-5307189
Email:
Avishag.Hassid@sheba.health.gov.il
At the Clinical Studies Unit - Liver Diseases, we provide patients with the opportunity to participate in cutting-edge therapeutic protocols that are exclusively available within the research framework. This opportunity arises years in advance of the drugs being registered and included in the health basket.
Conducting clinical trials is contingent upon obtaining approvals and adhering to stringent regulations set forth by the Israeli Ministry of Health and the FDA. Consequently, research approvals are only granted once evidence is provided of the drug's effectiveness and safety vis-à-vis to existing drugs. Participants in clinical trials receive even closer supervision than patients undergoing regular treatment. This close supervision allows for adjustments to the treatment based on the patient's individual condition and monitoring of their physical and mental wellbeing.
Today, the Liver Disease Center offers various clinical trials that include new treatment protocols for Hepatitis C, which was previously difficult to treat. These protocols involve the newest and most advanced medications available worldwide for the treatment of Hepatitis C - Interferon-free- which is given for short periods without side effects. Additionally, there are clinical trials for Primary Biliary Cirrhosis, Fatty Liver Disease, Hepatic Encephalopathy, Primary Sclerosing Cholangitis (PSC), and primary liver cancer.
